Bicycle Therapeutics Plc ADR (BCYC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -54,392 | -27,564 | -66,819 | -48,782 | -34,104 |
| Depreciation Amortization | 1,039 | 422 | 1,409 | 1,002 | 665 |
| Income taxes - deferred | -1,616 | -748 | -1,668 | N/A | N/A |
| Accounts receivable | -9,346 | 991 | 4,543 | 5,544 | 5,544 |
| Accounts payable and accrued liabilities | 1,341 | -255 | 1,196 | 270 | 2,225 |
| Other Working Capital | -12,447 | -9,493 | 39,329 | 36,014 | 2,972 |
| Other Operating Activity | 25,490 | 10,247 | 7,216 | 1,593 | -3,379 |
| Operating Cash Flow | $-49,931 | $-26,400 | $-14,794 | $-4,359 | $-26,077 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -14,555 | -4,756 | -2,030 | -963 | -794 |
| Investing Cash Flow | $-14,555 | $-4,756 | $-2,030 | $-963 | $-794 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 15,000 | 15,000 |
| Common Stock Issued | 645 | 450 | 305,725 | 115,061 | 74,611 |
| Other Financing Activity | 0 | 0 | 15,000 | 0 | 0 |
| Financing Cash Flow | $645 | $450 | $320,725 | $130,061 | $89,611 |
| Exchange Rate Effect | -2,070 | -603 | -1,211 | -1,205 | 8 |
| Beginning Cash Position | 438,680 | 438,680 | 135,990 | 135,990 | 135,990 |
| End Cash Position | 372,769 | 407,371 | 438,680 | 259,524 | 198,738 |
| Net Cash Flow | $-65,911 | $-31,309 | $302,690 | $123,534 | $62,748 |
| Free Cash Flow | |||||
| Operating Cash Flow | -49,931 | -26,400 | -14,794 | -4,359 | -26,077 |
| Capital Expenditure | -14,555 | -4,756 | -2,030 | -963 | -794 |
| Free Cash Flow | -64,486 | -31,156 | -16,824 | -5,322 | -26,871 |